(Q40406419)

20 September 2017

1 reference

title

Plasminogen activators and plasminogen activator inhibitors: biochemical aspects (English)

1 reference

20 September 2017

1 reference

Rijken DC

1 reference

20 September 2017

publication date

1 June 1995

1 reference

Best Practice and Research: Clinical Haematology

20 September 2017

published in

1 reference

20 September 2017

1 reference

20 September 2017

1 reference

20 September 2017

page(s)

291-312

1 reference

Tyrosine phosphorylation of human urokinase-type plasminogen activator

20 September 2017

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS0950-3536%2805%2980269-0

7 January 2021

Quantitation of urokinase antigen in plasma and culture media by use of an ELISA

1 reference

https://api.crossref.org/works/10.1016%2FS0950-3536%2805%2980269-0

7 January 2021

A Group of Patients with Impaired Plasma Fibrinolytic System and Selective Inhibition of Tissue Activator-Induced Fibrinolysis

1 reference

https://api.crossref.org/works/10.1016%2FS0950-3536%2805%2980269-0

7 January 2021

Mobile reactive centre of serpins and the control of thrombosis

1 reference

https://api.crossref.org/works/10.1016%2FS0950-3536%2805%2980269-0

7 January 2021

A novel sialylated N-acetylgalactosamine-containing oligosaccharide is the major complex-type structure present in Bowes melanoma tissue plasminogen activator

1 reference

https://api.crossref.org/works/10.1016%2FS0950-3536%2805%2980269-0

7 January 2021

Binding of tissue plasminogen activator to human endothelial cells. Importance of the B-chain as a ligand

1 reference

https://api.crossref.org/works/10.1016%2FS0950-3536%2805%2980269-0

7 January 2021

Kinetics of the inhibition of plasminogen activators by the plasminogen-activator inhibitor. Evidence for 'second-site' interactions

1 reference

https://api.crossref.org/works/10.1016%2FS0950-3536%2805%2980269-0

7 January 2021

Acceleration of the thrombin inactivation of single chain urokinase-type plasminogen activator (pro-urokinase) by thrombomodulin

1 reference

https://api.crossref.org/works/10.1016%2FS0950-3536%2805%2980269-0

7 January 2021

Role of the glycosaminoglycan component of thrombomodulin in its acceleration of the inactivation of single-chain urokinase-type plasminogen activator by thrombin.

1 reference

https://api.crossref.org/works/10.1016%2FS0950-3536%2805%2980269-0

7 January 2021

Solution structure of the fibrin binding finger domain of tissue-type plasminogen activator determined by 1H nuclear magnetic resonance

1 reference

https://api.crossref.org/works/10.1016%2FS0950-3536%2805%2980269-0

7 January 2021

alpha-Fucose-mediated binding and degradation of tissue-type plasminogen activator by HepG2 cells

1 reference

https://api.crossref.org/works/10.1016%2FS0950-3536%2805%2980269-0

7 January 2021

Tissue plasminogen activator has an O-linked fucose attached to threonine-61 in the epidermal growth factor domain

1 reference

https://api.crossref.org/works/10.1016%2FS0950-3536%2805%2980269-0

7 January 2021

Tissue plasminogen activator: the biochemistry and pharmacology of variants produced by mutagenesis

1 reference

https://api.crossref.org/works/10.1016%2FS0950-3536%2805%2980269-0

7 January 2021

Single-chain urokinase-type plasminogen activator does not possess measurable intrinsic amidolytic or plasminogen activator activities

1 reference

https://api.crossref.org/works/10.1016%2FS0950-3536%2805%2980269-0

7 January 2021

Interactions between the Finger and Kringle-2 Domains of Tissue-Type Plasminogen Activator and Plasminogen Activator Inhibitor-11

1 reference

https://api.crossref.org/works/10.1016%2FS0950-3536%2805%2980269-0

7 January 2021

Urokinase Inhibitor in Human Placenta

1 reference

https://api.crossref.org/works/10.1016%2FS0950-3536%2805%2980269-0

7 January 2021

Carbohydrate composition and presence of a fucose-protein linkage in recombinant human pro-urokinase

1 reference

https://api.crossref.org/works/10.1016%2FS0950-3536%2805%2980269-0

7 January 2021

Tissue-type plasminogen activator in somatostatin cells of rat pancreas and hypothalamus

1 reference

https://api.crossref.org/works/10.1016%2FS0950-3536%2805%2980269-0

7 January 2021

A comparative study of the promotion of tissue plasminogen activator and pro-urokinase-induced plasminogen activation by fragments D and E-2 of fibrin

1 reference

https://api.crossref.org/works/10.1016%2FS0950-3536%2805%2980269-0

7 January 2021

Fragment E-2 from fibrin substantially enhances pro-urokinase-induced Glu-plasminogen activation. A kinetic study using the plasmin-resistant mutant pro-urokinase Ala-158-rpro-UK.

1 reference

https://api.crossref.org/works/10.1016%2FS0950-3536%2805%2980269-0

7 January 2021

Converting tissue plasminogen activator to a zymogen: a regulatory triad of Asp-His-Ser

1 reference

https://api.crossref.org/works/10.1016%2FS0950-3536%2805%2980269-0

7 January 2021

Characterization of the activation of pro-urokinase by thermolysin

1 reference

https://api.crossref.org/works/10.1016%2FS0950-3536%2805%2980269-0

7 January 2021

Physical characterization of recombinant tissue plasminogen activator

1 reference

https://api.crossref.org/works/10.1016%2FS0950-3536%2805%2980269-0

7 January 2021

Kinetic analysis of the interaction between plasminogen activator inhibitor-1 and tissue-type plasminogen activator

1 reference

https://api.crossref.org/works/10.1016%2FS0950-3536%2805%2980269-0

7 January 2021

Serine phosphorylation of biosynthetic pro-urokinase from human tumor cells

1 reference

https://api.crossref.org/works/10.1016%2FS0950-3536%2805%2980269-0

7 January 2021

Structural basis of latency in plasminogen activator inhibitor-1

1 reference

https://api.crossref.org/works/10.1016%2FS0950-3536%2805%2980269-0

7 January 2021

Activation of thrombin-inactivated single-chain urokinase-type plasminogen activator by dipeptidyl peptidase I (cathepsin C).

1 reference

https://api.crossref.org/works/10.1016%2FS0950-3536%2805%2980269-0

7 January 2021

Conformational similarities between one-chain and two-chain tissue plasminogen activator (t-PA): implications to the activation mechanism on one-chain t-PA

1 reference

https://api.crossref.org/works/10.1016%2FS0950-3536%2805%2980269-0

7 January 2021

NMR studies of the dynamics of the multidomain protein urokinase-type plasminogen activator

1 reference

https://api.crossref.org/works/10.1016%2FS0950-3536%2805%2980269-0

7 January 2021

Complementary modes of action of tissue-type plasminogen activator and pro-urokinase by which their synergistic effect on clot lysis may be explained

1 reference

https://api.crossref.org/works/10.1016%2FS0950-3536%2805%2980269-0

7 January 2021

N-glycosylation and in vitro enzymatic activity of human recombinant tissue plasminogen activator expressed in Chinese hamster ovary cells and a murine cell line

1 reference

https://api.crossref.org/works/10.1016%2FS0950-3536%2805%2980269-0

7 January 2021

Cloning and expression of human tissue-type plasminogen activator cDNA in E. coli

1 reference

https://api.crossref.org/works/10.1016%2FS0950-3536%2805%2980269-0

7 January 2021

Quenching of the amidolytic activity of one-chain tissue-type plasminogen activator by mutation of lysine-416.

1 reference

https://api.crossref.org/works/10.1016%2FS0950-3536%2805%2980269-0

7 January 2021

Structure elucidation of sulphated oligosaccharides from recombinant human tissue plasminogen activator expressed in mouse epithelial cells

1 reference

https://api.crossref.org/works/10.1016%2FS0950-3536%2805%2980269-0

7 January 2021

Isolation and characterization of three different carbohydrate chains from melanoma tissue plasminogen activator

1 reference

https://api.crossref.org/works/10.1016%2FS0950-3536%2805%2980269-0

7 January 2021

Substrate specificity of tissue-type and urokinase-type plasminogen activators

1 reference

https://api.crossref.org/works/10.1016%2FS0950-3536%2805%2980269-0

7 January 2021

Kinetic analysis of the interaction between type 1 plasminogen activator inhibitor and vitronectin and evidence that the bovine inhibitor binds to a thrombin-derived amino-terminal fragment of bovine vitronectin

1 reference

https://api.crossref.org/works/10.1016%2FS0950-3536%2805%2980269-0

7 January 2021

Specific anionic residues of the recombinant kringle 2 domain of tissue-type plasminogen activator that are responsible for stabilization of its interaction with omega-amino acid ligands

1 reference

https://api.crossref.org/works/10.1016%2FS0950-3536%2805%2980269-0

7 January 2021

Kinetics of inhibition of tissue-type and urokinase-type plasminogen activator by plasminogen-activator inhibitor type 1 and type 2

1 reference

https://api.crossref.org/works/10.1016%2FS0950-3536%2805%2980269-0

7 January 2021

Specificity of human natural antibody to recombinant tissue-type plasminogen activator (t-PA) expressed in mouse C127 cells

1 reference

https://api.crossref.org/works/10.1016%2FS0950-3536%2805%2980269-0

7 January 2021

Studies of recombinant plasminogen activator inhibitor-1 in rabbits. Pharmacokinetics and evidence for reactivation of latent plasminogen activator inhibitor-1 in vivo

1 reference

https://api.crossref.org/works/10.1016%2FS0950-3536%2805%2980269-0

7 January 2021

Involvement of finger domain and kringle 2 domain of tissue-type plasminogen activator in fibrin binding and stimulation of activity by fibrin

1 reference

https://api.crossref.org/works/10.1016%2FS0950-3536%2805%2980269-0

7 January 2021

Crystal structure of the kringle 2 domain of tissue plasminogen activator at 2.4-.ANG. resolution

1 reference

https://api.crossref.org/works/10.1016%2FS0950-3536%2805%2980269-0

7 January 2021

https://api.crossref.org/works/10.1016%2FS0950-3536%2805%2980269-0

1 reference

7 January 2021

Purification and identification of two structural variants of porcine tissue plasminogen activator by affinity adsorption on fibrin

1 reference

https://api.crossref.org/works/10.1016%2FS0950-3536%2805%2980269-0

7 January 2021

39-kD protein inhibits tissue-type plasminogen activator clearance in vivo

1 reference

https://api.crossref.org/works/10.1016%2FS0950-3536%2805%2980269-0

7 January 2021

Involvement of aspartic and glutamic residues in kringle-2 of tissue-type plasminogen activator in lysine binding, fibrin binding and stimulation of activity as revealed by chemical modification and oligonucleotide-directed mutagenesis.

1 reference

https://api.crossref.org/works/10.1016%2FS0950-3536%2805%2980269-0

7 January 2021

10.1016/S0950-3536(05)80269-0

Identifiers

DOI

1 reference

20 September 2017

1 reference